{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:19:41Z","timestamp":1792700381441,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hyperthyroidism is characterized by an increase in the synthesis and secretion of thyroid hormones in the thyroid gland, and the most common cause of overproduction of thyroid hormones is Graves\u2019 disease (GD). Long-term disease models of hyperthyroidism have been established. In general, methods to induce GD include transfection of fibroblasts, injecting plasmids or adenovirus containing thyroid stimulating hormone receptor (TSHR) or TSHR subunit, and exogenous artificial thyroid hormone supplementation. Fortunately, in mouse studies, novel treatments for GD and Graves\u2019 orbitopathy (GO) were discovered. It has been reported that prophylactic administration of TSHR A subunit protein in genetically susceptible individuals could induce immune tolerance and provide protection for the future development of GD. Biologically active monoclonal antibody against intracellular adhesion molecule-1 (ICAM-1 mAb) and siRNA targeting TSHR can also be used to treat GD. Moreover, new potential therapeutic targets have been identified in GO mouse models, and these targets could present novel therapeutic approaches. Besides, human placental mesenchymal stem cells (hPMSCs) into the orbit, fucoxanthin and icariin may be new alternative therapies that could be used in addition to the existing drugs, although further research is needed.<\/jats:p>","DOI":"10.3389\/fendo.2022.929750","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T07:16:47Z","timestamp":1655882207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Insight Into Mouse Models of Hyperthyroidism"],"prefix":"10.3389","volume":"13","author":[{"given":"Mengyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet"},{"key":"B2","article-title":"Hyperthyroidism: Diagnosis and Treatment","volume":"93","author":"Kravets","year":"2016","journal-title":"Am Fam Physician"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid Disease and the Heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02311-7","article-title":"Lessons From Mouse Models of Graves' Disease","volume":"68","author":"Eckstein","year":"2020","journal-title":"Endocrine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-09352007000500022","article-title":"Model of Induction of Thyroid Dysfunctions in Adult Female Mice","volume":"59","author":"Ferreira","year":"2007","journal-title":"Arq Bras Med Vet Zootec"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02399.x","article-title":"Evidence That Factors Other Than Particular Thyrotropin Receptor T Cell Epitopes Contribute to the Development of Hyperthyroidism in Murine Graves' Disease","volume":"135","author":"Pichurin","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02483.x","article-title":"Induction of Hyperthyroidism in Mice by Intradermal Immunization With DNA Encoding the Thyrotropin Receptor","volume":"136","author":"Barrett","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0181","article-title":"Attenuation of Induced Hyperthyroidism in Mice by Pretreatment With Thyrotropin Receptor Protein: Deviation of Thyroid-Stimulating to Nonfunctional Antibodies","volume":"150","author":"Misharin","year":"2009","journal-title":"Endocrinology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00306","article-title":"Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice","volume":"159","author":"Jansson","year":"2018","journal-title":"Endocrinology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5603\/EP.a2021.0087","article-title":"Immunotherapy With a Biologically Active ICAM-1 mAb and an siRNA Targeting TSHR in a BALB\/c Mouse Model of Graves' Disease","volume":"72","author":"Wang","year":"2021","journal-title":"Endokrynol Pol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.11074","article-title":"Induction of Graves-Like Disease in Mice by Immunization With Fibroblasts Transfected With the Thyrotropin Receptor and a Class II Molecule","volume":"93","author":"Shimojo","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.3.6599","article-title":"Regulation and Transfer of a Murine Model of Thyrotropin Receptor Antibody Mediated Graves' Disease","volume":"140","author":"Kita","year":"1999","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7665","article-title":"Genetic Immunization of Outbred Mice With Thyrotropin Receptor cDNA Provides a Model of Graves' Disease","volume":"105","author":"Costagliola","year":"2000","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.3.1458","article-title":"Genetic Immunization Against the Human Thyrotropin Receptor Causes Thyroiditis and Allows Production of Monoclonal Antibodies Recognizing the Native Receptor","volume":"160","author":"Costagliola","year":"1998","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/105072503321582024","article-title":"A Major Role for non-Major Histocompatibility Complex Genes But Not for Microorganisms in a Novel Murine Model of Graves' Hyperthyroidism","volume":"13","author":"Nagayama","year":"2003","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10688","article-title":"Antibodies Against Thyroid-Stimulating Hormone Receptor Cause Maternal-Neonatal Transmission of Graves' Disease","volume":"22","author":"Yu","year":"2021","journal-title":"Exp Ther Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0148","article-title":"An Improved Mouse Model of Graves Disease by Once Immunization With Ad-Tshr289","volume":"66","author":"Tang","year":"2019","journal-title":"Endocr J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202006_21536","article-title":"Effect of \u03b2-Casomorphin-7 on Myocardial Hypertrophy in Hyperthyroidism-Induced Cardiomyopathy","volume":"24","author":"Sheng","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12020-016-1020-8","article-title":"Efficacy of Protocols for Induction of Chronic Hyperthyroidism in Male and Female Mice","volume":"54","author":"Engels","year":"2016","journal-title":"Endocrine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.12.4589","article-title":"Genetic Control of Anti-Thyrotropin Receptor Antibody Generation in H-2K Mice Immunized With Thyrotropin Receptor-Transfected Fibroblasts","volume":"82","author":"Yamaguchi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0716","article-title":"Susceptibility Rather Than Resistance to Hyperthyroidism is Dominant in a Thyrotropin Receptor Adenovirus-Induced Animal Model of Graves' Disease as Revealed by BALB\/c-C57BL\/6 Hybrid Mice","volume":"145","author":"Chen","year":"2004","journal-title":"Endocrinology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating Gut Microbiota in a Mouse Model of Graves' Orbitopathy and its Impact on Induced Disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317069","article-title":"The Thyrotropin Receptor Autoantigen in Graves Disease is the Culprit as Well as the Victim","volume":"111","author":"Chen","year":"2003","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1077","article-title":"An Improved Graves' Disease Model Established by Using In Vivo Electroporation Exhibited Long-Term Immunity to Hyperthyroidism in BALB\/c Mice","volume":"148","author":"Kaneda","year":"2007","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1024","article-title":"Regulation of Graves' Hyperthyroidism With Naturally Occurring CD4(+)CD25(+) Regulatory T Cells in a Mouse Model","volume":"147","author":"Saitoh","year":"2006","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80439-2","article-title":"Stat6 is Required for Mediating Responses to IL-4 and for Development of Th2 Cells","volume":"4","author":"Kaplan","year":"1996","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 Responses and Enhanced Development of Th2 Cells in Stat4-Deficient Mice","volume":"382","author":"Kaplan","year":"1996","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1031","article-title":"Differential Requirement of Signal Transducer and Activator of Transcription-4 (Stat4) and Stat6 in a Thyrotropin Receptor-289-Adenovirus-Induced Model of Graves' Hyperthyroidism","volume":"147","author":"Land","year":"2006","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1813","article-title":"Prolonged TSH Receptor A Subunit Immunization of Female Mice Leads to a Long-Term Model of Graves' Disease, Tachycardia, and Cardiac Hypertrophy","volume":"156","author":"Holthoff","year":"2015","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.prp.2006.09.005","article-title":"Ehrlich Tumor as Model to Study Artificial Hyperthyroidism Influence on Breast Cancer","volume":"203","author":"Ferreira","year":"2007","journal-title":"Pathol Res Pract"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' Orbitopathy (EUGOGO) Clinical Practice Guidelines for the Medical Management of Graves' Orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0305-4","article-title":"New Insights Into the Pathogenesis and Nonsurgical Management of Graves Orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1045-9","article-title":"Current and Emerging Treatment Strategies for Graves' Orbitopathy","volume":"79","author":"Genere","year":"2019","journal-title":"Drugs"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1576","article-title":"Cutting Edge: Retrobulbar Inflammation, Adipogenesis, and Acute Orbital Congestion in a Preclinical Female Mouse Model of Graves' Orbitopathy Induced by Thyrotropin Receptor Plasmid-In Vivo Electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000508790","article-title":"A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies","volume":"9","author":"Diana","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1055\/s-0035-1564108","article-title":"Modeling Graves' Orbitopathy in Experimental Graves' Disease","volume":"47","author":"Banga","year":"2015","journal-title":"Horm Metab Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0088","article-title":"A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit","volume":"31","author":"Zhang","year":"2021","journal-title":"Thyroid"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.8.26","article-title":"Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation","volume":"9","author":"Amarnani","year":"2020","journal-title":"Trans Vision Sci Technol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64402-9","article-title":"Enhanced Orbital Adipogenesis in a Mouse Model of T-Cell-Mediated Autoimmunity, Zymosan A-Treated SKG Mice: Implications for Graves' Ophthalmopathy","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' Disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/aps.2013.133","article-title":"Diosgenin Relieves Goiter via the Inhibition of Thyrocyte Proliferation in a Mouse Model of Graves' Disease","volume":"35","author":"Cai","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1845","article-title":"Cyclic Peptides for Effective Treatment in a Long-Term Model of Graves Disease and Orbitopathy in Female Mice","volume":"158","author":"Holthoff","year":"2017","journal-title":"Endocrinology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00045","article-title":"Icariin Inhibits AMPK-Dependent Autophagy and Adipogenesis in Adipocytes In Vitro and in a Model of Graves' Orbitopathy In Vivo","volume":"8","author":"Li","year":"2017","journal-title":"Front Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13287-019-1348-0","article-title":"Human Placenta-Derived Mesenchymal Stem Cells Ameliorate Orbital Adipogenesis in Female Mice Models of Graves' Ophthalmopathy","volume":"10","author":"Park","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v19i5.4","article-title":"Fucoxanthin Improves Functional Recovery of Orbitopathy in Graves' Disease by Downregulating IL-17 mRNA Expression in a Mouse Model","volume":"19","author":"Chai","year":"2020","journal-title":"Trop J Pharm Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0737","article-title":"Induction of Murine Neonatal Tolerance Against Graves' Disease Using Recombinant Adenovirus Expressing the TSH Receptor A-Subunit","volume":"152","author":"Wu","year":"2011","journal-title":"Endocrinology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.929750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:09:15Z","timestamp":1675901355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.929750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":46,"alternative-id":["10.3389\/fendo.2022.929750"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.929750","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"article-number":"929750"}}